Short Interest in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Rises By 5.4%

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report) saw a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 8,250,000 shares, a growth of 5.4% from the January 15th total of 7,830,000 shares. Approximately 22.6% of the shares of the stock are sold short. Based on an average daily volume of 1,490,000 shares, the short-interest ratio is currently 5.5 days.

Institutional Trading of Ginkgo Bioworks

Several large investors have recently made changes to their positions in DNA. PFG Investments LLC bought a new stake in shares of Ginkgo Bioworks during the third quarter worth $1,541,000. Forbes J M & Co. LLP bought a new position in Ginkgo Bioworks in the third quarter valued at about $1,019,000. BNP Paribas Financial Markets bought a new position in Ginkgo Bioworks in the third quarter valued at about $1,287,000. Verition Fund Management LLC bought a new position in Ginkgo Bioworks in the third quarter valued at about $792,000. Finally, PDT Partners LLC bought a new position in Ginkgo Bioworks in the third quarter valued at about $1,199,000. Institutional investors own 78.63% of the company's stock.

Ginkgo Bioworks Trading Down 5.0 %

Shares of DNA stock traded down $0.58 during trading hours on Friday, hitting $10.86. 2,027,060 shares of the company's stock were exchanged, compared to its average volume of 1,691,831. The company has a 50-day moving average price of $11.48. The firm has a market cap of $623.93 million, a PE ratio of -0.83 and a beta of 1.16. Ginkgo Bioworks has a 52 week low of $5.26 and a 52 week high of $64.40.

Ginkgo Bioworks Company Profile

Ginkgo Bioworks Holdings, Inc, together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries.